Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Astellas Pharma Global Development, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Employees: -

Market Cap: -

Website

Clinical Trials

Drug Interaction Study of Isavuconazole and Digoxin

Phase 1

Completed

Conditions: Pharmacokinetics of Isavuconazole
Pharmacokinetics of Digoxin
Healthy Volunteers

Interventions: Drug: Isavuconazole
Drug: digoxin

First Posted Date: 2012-04-20

Last Posted Date: 2015-09-01

Lead Sponsor: Astellas Pharma Global Development, Inc.

Target Recruit Count: 24

Registration Number: NCT01582412

Locations: 🇺🇸
Parexel International, Baltimore, Maryland, United States

Bioavailability of ASKP1240 in Healthy Subjects After Intravenous and Subcutaneous Administration of ASKP1240

Phase 1

Completed

Conditions: Pharmacokinetics of ASKP1240
Pharmacodynamics of ASKP1240
Healthy Volunteers

Interventions: Drug: ASKP1240

First Posted Date: 2012-04-20

Last Posted Date: 2012-12-10

Lead Sponsor: Astellas Pharma Global Development, Inc.

Target Recruit Count: 24

Registration Number: NCT01582399

Locations: 🇺🇸
Parexel, Baltimore, Maryland, United States

Drug Interaction Study of Isavuconazole and Methadone

Phase 1

Completed

Conditions: Pharmacokinetics of Isavuconazole
Pharmacokinetics of Methadone
Healthy Volunteers

Interventions: Drug: Isavuconazole
Drug: Methadone

First Posted Date: 2012-04-20

Last Posted Date: 2012-07-02

Lead Sponsor: Astellas Pharma Global Development, Inc.

Target Recruit Count: 24

Registration Number: NCT01582425

Locations: 🇺🇸
Parexel International, LLC, Glendale, California, United States

A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis

Phase 2

Completed

Conditions: Arthritis, Rheumatoid

Interventions: Drug: Placebo
Drug: peficitinib

First Posted Date: 2012-03-29

Last Posted Date: 2025-05-21

Lead Sponsor: Astellas Pharma Global Development, Inc.

Target Recruit Count: 289

Registration Number: NCT01565655

Locations: 🇺🇸
Achieve Clinical Research, LLC, Birmingham, Alabama, United States
🇺🇸
University of California San Diego, La Jolla, California, United States
🇺🇸
Desert Medical Advances, Palm Desert, California, United States

and more 35 locations

Study of ASKP1240 After a Single Intravenous Dose at Escalating Dose Levels in Healthy Subjects

Phase 1

Completed

Conditions: Pharmacokinetics of ASKP1240
Healthy Volunteers

Interventions: Drug: ASP1240
Drug: Placebo

First Posted Date: 2012-03-29

Last Posted Date: 2012-12-10

Lead Sponsor: Astellas Pharma Global Development, Inc.

Target Recruit Count: 109

Registration Number: NCT01565681

Locations: 🇺🇸
Parexel, Baltimore, Maryland, United States

Study of the Effect of Repeat Doses of Isavuconazole on Cardiac Repolarization

Phase 1

Completed

Conditions: Pharmacokinetics of Isavuconazole
Healthy Volunteers

Interventions: Drug: Isavuconazole
Drug: Placebo
Drug: Moxifloxacin

First Posted Date: 2012-03-29

Last Posted Date: 2012-07-09

Lead Sponsor: Astellas Pharma Global Development, Inc.

Target Recruit Count: 161

Registration Number: NCT01565720

Locations: 🇺🇸
Parexel, Glendale, California, United States

Study of the Effect of Renal Impairment on the Pharmacokinetics of Isavuconazole.

Phase 1

Completed

Conditions: Pharmacokinetics of Isavuconazole
Healthy Volunteers
Renal Impaired

Interventions: Drug: isavuconazole

First Posted Date: 2012-03-16

Last Posted Date: 2015-09-01

Lead Sponsor: Astellas Pharma Global Development, Inc.

Target Recruit Count: 49

Registration Number: NCT01555866

Locations: 🇺🇸
DaVita Research, Denver, Colorado, United States
🇺🇸
Clinical Pharmacology Miami, Miami, Florida, United States
🇺🇸
DaVita Clinical Research, Minneapolis, Minnesota, United States

A Study to Look at How a Single Oral Dose of 14C-OSI-906 is Absorbed, Broken Down and Eliminated in the Body

Phase 1

Completed

Conditions: Advanced Solid Tumors
Pharmacokinetics of 14C-OSI-906

Interventions: Drug: radio-labeled OSI-906
Drug: OSI-906

First Posted Date: 2012-02-09

Last Posted Date: 2024-11-07

Lead Sponsor: Astellas Pharma Global Development, Inc.

Target Recruit Count: 5

Registration Number: NCT01529684

Locations: 🇺🇸
Northwest Medical Specialties, PLLC, Tacoma, Washington, United States
🇺🇸
Comprehensive Clinical Development NW, Inc., Tacoma, Washington, United States

Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal Candidiasis

Phase 3

Terminated

Conditions: Candidiasis

Interventions: Drug: amphotericin B deoxycholate
Drug: micafungin

First Posted Date: 2008-12-30

Last Posted Date: 2015-11-04

Lead Sponsor: Astellas Pharma Global Development, Inc.

Target Recruit Count: 30

Registration Number: NCT00815516

Locations: 🇺🇸
Children's Hospital of Orange County, Orange, California, United States
🇺🇸
UMDNJ/Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States
🇺🇸
Duke University, Durham, North Carolina, United States

and more 14 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy